Hypertension and current issues in compliance and patient outcomes

Abstract

Economic and human costs associated with untreated or inadequately controlled hypertension and its complications continue to be an issue in the United States despite the availability of numerous antihypertensive agents. Knowledge of hypertension, product profiles, tolerability concerns, convenience of dosing, health-related quality of life effects, and cost of therapy are some of the factors that may influence the compliance of patients to their medication regimens. Recent reports on patient noncompliance have focused on patient-provider relationships, psychosocial barriers, home blood pressure monitoring, and electronic monitoring systems to improve blood pressure control. The use of health-related quality of life assessment in antihypertensive studies and in routine clinical practice provides another opportunity to optimize a patient's regimen for short- and long-term hypertension control in a cost-effective manner.

Medication barriers and anti-hypertensive medication adherence: The moderating role of locus of control

“…Research has generally found that medication barriers are highly associated with poor medication adherence (Allen, 1998;Clark, 1991;Richardson, Simons-Morton, & Annegers, 1993;Zyczynski & Coyne, 2000). Medication barriers often encompass patient specific barriers such as forgetfulness, beliefs, and attitudes but can also encompass barriers that are medication specific, disease specific, or logistic (Bosworth, 2005;Ogedegbe, Harrison, Robbins, Mancuso, & Allegrante, 2004).…”

Identification of psychosocial factors of noncompliance in hypertensive patients

“…2,3 However, despite the expanding choices in antihypertensive treatments, less than one-third of hypertensive adults have their BP adequately controlled in the United States. 4 In Malaysia, the Second National Health Morbidity Survey reported that the prevalence of hypertension among adults aged 30 years and above was 29.9%, of whom 32.6% had stopped treatment since diagnosis. The main reasons given for noncompliance are predominantly based around poor communication.…”

Factors influencing the provision of adherence support by community pharmacists: A structural equation modeling approach

“…Previous studies have found this to be one of the 319 most effective strategies for improving adherence to medications particularly for unintentional 320 non-adherence related to forgetfulness or confusion. 2,19,33 In Australia, community pharmacists The "number of full time equivalent staff' was found to be significantly associated with 405 pharmacists' provision of strategies used to support adherence. Perhaps this is not surprising as 406 pharmacists who have adequate number of pharmacy technicians may be able to spend more 407 time with patients to provide adherence support, or those who are oriented to providing 408 professional services ensure that they are adequately staffed".…”